SCHEDULE 13G (ORBIMED CAPITAL LLC)

Company

ACADIA PHARMACEUTICALS INC

Filed

September 3, 2004

Accession Number

0000947871-04-002107

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →